| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
30,140 |
26,875 |
$1.19M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
14,265 |
4,327 |
$284K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,964 |
4,185 |
$176K |
| 36902 |
|
596 |
564 |
$81K |
| 90961 |
|
832 |
756 |
$26K |
| 99223 |
Prolong inpt eval add15 m |
433 |
412 |
$9K |
| 99255 |
|
78 |
70 |
$7K |
| 99233 |
Prolong inpt eval add15 m |
100 |
65 |
$4K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
347 |
267 |
$3K |
| 37252 |
|
15 |
13 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,554 |
1,634 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27 |
25 |
$804.41 |
| 99205 |
Prolong outpt/office vis |
16 |
14 |
$512.70 |
| 36589 |
|
12 |
12 |
$302.21 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
190 |
171 |
$268.20 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,717 |
1,067 |
$70.12 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,862 |
1,073 |
$27.89 |